March 27, 2020 – ROCHESTER, NY – Bio-Optronics, makers of the industry-leading CCTrialSuite®, the industry’s most comprehensive set of integrated clinical research management products, is currently working with multiple hospitals and health systems throughout the US that are starting COVID-19 clinical trials.
As these organizations begin the much-needed research to find a cure for COVID-19, they will be leveraging Bio-Optronics’ advanced CTMS, eRegulatory and eSource applications, in addition to other products designed to streamline safe, secure two-way patient communication. All of these applications are part of the CCTrialSuite®, and these tools facilitate streamlined clinical operations which can be conducted remotely to ensure safety for patients and investigators.
Bio-Optronics’ clients include major hospitals, health systems and academic centers, many of whom are currently operating some of the most innovative clinical trials offices in the world. The Bio-Optronics team is honored to help these businesses quickly uncover treatments to the current COVID-19 pandemic.
Bio-Optronics is a leading software and services company that creates user-focused applications for healthcare organizations that positively impact business performance. With applications focused on clinical research, automated resource utilization and patient safety, Bio-Optronics software is used by thousands of healthcare organizations worldwide to simplify complex business processes and enhance overall quality and efficiency.